References
Dalakas MC, Rakocevic G, Salajegheh M, Dambrosia JM, Hahn AF, Raju R, McElroy B (2009) Placebo controlled-trial of rituximab in IgM anti-MAG antibody demyelinating neuropathy. Ann Neurol; 65(3):286–293
Joint Task Force of the EFNS and the PNS (2010) Guideline on management of paraproteinemic demyelinating neuropathies Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society—first revision. J Peripher Nerv Syst 15(3):185–195
Graham RC, Hughes RA (2006) A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. J Neurol Neurosurg Psychiatry 77:973–976
Merkies IS, Schmitz PI, van de Meche FG, van Doorn PA (2002) Psychometric evaluation of new sensory scale in immune mediated polyneuropathies. Neurology 54:943–949
Delmont E, Benaïm C, Launay M, Sacconi S, Soriani MH, Desnuelle C (2009) Do patients having a decrease in SNAP amplitude during the course of MMN present with a different condition? J Neurol 256(11):1876–1880
Latov N, Renaud S (2004) Effector mechanisms in anti-MAG antibody-mediated and other demyelinating neuropathies. J Neurol Sci 220:127–129
Renaud S, Gregor M, Fuhr P, Lorenz D, Deuschl G, Gratwohl A, Steck AJ (2003) Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies. Muscle Nerve 27(5):611–615
Renaud S, Fuhr P, Gregor M, Schweikert K, Lorenz D, Daniels C, Deuschl G, Gratwohl A, Steck AJ (2006) High-dose rituximab and anti-MAG-associated polyneuropathy. Neurology 66(5):742–744
Benedetti L, Briani C, Grandis M, Vigo T, Gobbi M, Ghiglione E, Carpo M, Cocito D, Caporale CM, Sormani MP, Mancardi GL, Nobile-Orazio E, Schenone A (2007) Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M. J Peripher Nerv Syst 12(2):102–107
Niermeijer JM, Eurelings M, Lokhorst HL, van der Pol WL, Franssen H, Wokke JH, Notermans NC (2009) Rituximab for polyneuropathy with IgM monoclonal gammopathy. J Neurol Neurosurg Psychiatry 80(9):1036–1039
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Delmont, E., Jeandel, P.Y., Benaïm, C. et al. Treatment with rituximab in patients with polyneuropathy with anti-MAG antibodies. J Neurol 258, 1717–1719 (2011). https://doi.org/10.1007/s00415-011-5994-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-011-5994-0